stockmarketproxy
/
ZBHNYSE SEC EDGAR

ZIMMER BIOMET HOLDINGS, INC.

Orthopedic, Prosthetic & Surgical Appliances & Supplies·WARSAW, IN·FY end 12/31·CIK 1136869
OverviewFinancialsCompensationGovernanceInsidersFilings

Financials

5-year history · USD
MetricFY 2025FY 2024FY 2023FY 2022FY 2021Trend
Revenue$8.2B$7.7B$7.4B$6.9B$7.8B
Gross Profit——————
Operating Income$1.1B$1.3B$1.3B$696.3M$780.1M
Net Income$705.1M$903.8M$1.0B$231.4M$401.6M
Operating CF$1.7B———$1.5B
Capex$224.5M$203.8M$291.1M$187.9M$172.0M
Free Cash Flow$1.5B———$1.3B
Buybacks$487.0M$868.0M$692.2M$126.4M—
Dividends$190.3M$196.0M$200.9M$201.2M$200.1M
Gross Margin——————
Operating Margin13.3%16.7%17.3%10.0%10.0%
Net Margin8.6%11.8%13.8%3.3%5.1%
FCF Margin17.9%———16.9%
R&D / Revenue——————
Effective Tax15.1%12.7%4.0%27.8%3.9%
Debt / Equity0.550.510.390.430.43
Buybacks / FCF33.1%—————

Peer comparison

Orthopedic, Prosthetic & Surgical Appliances & Supplies · 5 peers
CEO Pay Ratio
ZBH
200:1
ISRG
147:1
ALGN
610:1
EW
194:1
STE
151:1
MSA
88:1
CEO total comp
ZBH
—
ISRG
$21M
ALGN
$19M
EW
$17M
STE
$11M
MSA
$6M
Net Margin
ZBH
8.6%
ISRG
28.4%
ALGN
10.2%
EW
17.7%
STE
11.3%
MSA
4.6%